期刊文献+

倍他乐克联合阿托伐他汀对舒张性心力衰竭心功能及运动耐量的影响 被引量:3

Effects of Betaloc in combination with Atorvastatin on cardiac function and exercise tolerance in patients with diastolic heart failure
下载PDF
导出
摘要 目的观察倍他乐克联合阿托伐他汀对舒张性心力衰竭心功能及运动耐量的影响,方法入选60例舒张性心力衰竭患者,随机分为两组,一组为对照组接受倍他乐克治疗,另一组为治疗组倍他乐克联合阿托伐他汀,两组疗程均为12周,观察及比较治疗前后心功能,运动耐量,评估两组治疗的临床效果。结果治疗组在心功能,运动耐量改善方面均优于对照组,差异有统计学意义(P<0.05)。结论倍他乐克联合阿托伐他汀能有效提高舒张性心力衰竭患者心功能及运动耐量。 Objective To observe the effects of Betaloc in combination with Atorvastatin on cardiac function and exercise tolerance in patients with diastolic heart failure.Methods 60 patients with diastolic heart failure were randomly divided into tow groups,the control group receive Betaloc,and the treatment group receive betaloc puls Atorvastatin theraphy,they were treated for 12 weeks,the changes of cardiac function and exercise tolerance were observed and compared before and after treatment to evaluate the clinical effects of tow groups.Results The improvement of the treatment group'results of cardiac function and exercise tolerance were better than the control group,the differences were statistically significant(P〈0.05).Conclusion Betaloc in combination with Atorvastatin can effectively improve cardiac function and exercise tolerance in patients with diastolic heart failure.
作者 王仲 孙彦素
出处 《中国现代药物应用》 2012年第5期8-9,共2页 Chinese Journal of Modern Drug Application
关键词 舒张性心力衰竭 心功能 运动耐量 Diastolic heart failure Cardiac function Exercise tolerance
  • 相关文献

参考文献7

  • 1周裔忠,祝善俊,于林君.舒张性心力衰竭诊断与治疗的进展[J].中华心血管病杂志,2004,32(5):478-480. 被引量:87
  • 2杨新春;那开宪;陈瑾.心力衰竭临床与实践[M]北京:人民卫生出版社,2008248-249.
  • 3张凤如.舒张性心力衰竭的研究现状[J].中华老年多器官疾病杂志,2006,5(2):93-95. 被引量:1
  • 4Yamamoto K,Masuyama T,Sakata Y. Myocardial stiffness is determined by ventricular fibrosis,but not by compensatory or excesrsive hypertrophy in hypertensive heart[J].Cardiovascular Research,2002,(01):76-82.
  • 5王蕾,张世杰,王海鹏,邹操,蒋彬,赵彩明,刘志华,蒋文平.阿托伐他汀对兔舒张性心力衰竭模型心室重构的影响[J].中国循环杂志,2010,25(3):223-226. 被引量:16
  • 6Liao JK,Laufs U. Pleiotropic effects of statins[J].Annual Review of Pharmacology and Toxicology,2005.89-118.
  • 7Fukuta H,Sane DC,Brucks S. Statin therapy may be associated with lower mortality in patients with diastolic heart failure:a preliminary report[J].Circulation,2005,(03):357-363.doi:10.1161/CIRCULATIONAHA.104.519876.

二级参考文献24

  • 1徐浩,王安才,杨解人.阿托伐他汀改善心室重构作用及其抗氧化机制研究[J].心脑血管病防治,2005,5(6):16-18. 被引量:12
  • 2徐琳,李志梁,赵连友,刘映峰,李公信,丁明学,赵一俏,傅强,赵霞.辛伐他汀对鼠心脏成纤维细胞DNA合成的影响[J].南方医科大学学报,2006,26(2):205-207. 被引量:10
  • 3谭安雄,李金成,粟顺善,姜德建.阿托伐他汀改善自发性高血压大鼠心室重构的机制[J].中华高血压杂志,2007,15(6):497-500. 被引量:10
  • 4Kelynaek KJ, Hewitson TD, Martic M, et al. Lovastatin down regulates renal myofibroblast function in vitro. Nephron,2002,91:701-707.
  • 5Porter KE, Turner NA, O'Regan DJ, et al. Simvastatin reduces human atrial myofibmblast proliferation independently of cholesmrol lowering via inhibition of RhoA. Cardiovasc Res ,200d ,6! :745-755.
  • 6Baicu CF, Zile MR, Aurigemma GP, et al. Left ventricular systolic performance ,function and contractility in patients with diastolic heart failure. Circulation ,2005,111:2306-2312.
  • 7Patel R, Nagueh SF, Tsybanleva N, ct al. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation, 2001,104 : 317 -324.
  • 8Nishikawa H,Miura S,Zhang B,et al . Statins induce the regression of left vent ricular mass in patients with angina. Circ J ,2004,68:121-125.
  • 9Maack C, Kartes T, Kilter H, et al. Oxygen free radical release in human failing myocardium is associated with increased activity of Rael-GTPase and represents a target for statin treatment. Circulation,2003, 108 : 1567-1574.
  • 10Ito M, Adachi T, Pimentel DR, et al. Statins inhibit beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes via a Rac1 -dependent mechanism. Circulation ,2004,110:412-418.

共引文献101

同被引文献21

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部